Summary
Ependymomas are glial tumours of the brain and spinal cord. The most frequent genetic change in sporadic ependymoma is monosomy 22, suggesting the presence of an ependymoma tumour suppressor gene on that chromosome. Clustering of ependymomas has been reported to occur in some families. From an earlier study in a family in which four cousins developed an ependymoma, we concluded that an ependymoma-susceptibility gene, which is not the NF2 gene in 22q12, might be located on chromosome 22. To localize that gene, we performed a segregation analysis with chromosome 22 markers in this family. This analysis revealed that the susceptibility gene may be located proximal to marker D22S941 in 22pter–22q11.2. Comparative genomic hybridization showed that monosomy 22 was the sole detectable genetic aberration in the tumour of one of the patients. Loss of heterozygosity studies in that tumour revealed that, in accordance to Knudson’s two-hit theory of tumorigenesis, the lost chromosome 22 originated from the parent presumed to have contributed the wild-type allele of the susceptibility gene. Thus, our segregation and tumour studies collectively indicate that an ependymoma tumour suppressor gene may be present in region 22pter–22q11.2.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Birch, BD, Johnson, JP, Parsa, A, Desai, RD, Yoon, JT, Lycette, CA, Li, YM & Bruce, JN (1996). Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 39: 135–140.
Bijlsma, EK, Voesten, AMJ, Bijleveld, EH, Troost, D, Westerveld, A, Mérel, P, Thomas, G & Hulsebos, TJM (1995). Molecular analysis of genetic changes in ependymomas. Genes Chromosomes Cancer 13: 272–277.
Cavenee, WK, Dryja, TP, Phillips, RA, Benedict, WF, Godbout, R, Gallie, BL, Murphree, AL, Strong, LC & White, RL (1983). Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779–784.
Collins, JE, Cole, CG, Smink, LJ, Garrett, CL, Leversha, MA, Soderlund, CA, Masien, GL, Everett, LA, Rice, KM, Coffey, AJ, Gregory, SG, Gwilliam, R, Dunham, A, Davies, AF, Hassock, S, Todd, CM, Lehrach, H, Hulsebos, TJM, Weissenbach, J, Morrow, B, Kucherlapati, RS, Wadey, R, Scambler, PJ, Kim, U-J, Simon, MI, Peyrard, M, Xie, Y-G, Carter, NP, Durbin, R, Dumanski, JP, Bentley, DR & Dunham, I (1995). A high-density YAC contig map of human chromosome 22. Nature 377: 367S–379S.
Dib, C, Faure, S, Fizames, C, Samson, D, Drouot, N, Vignal, A, Millasseau, P, Marc, S, Hazan, J, Seboun, E, Lathrop, M, Gyapay, G, Morissette, J & Weissenbach, J (1996). A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152–154.
Hamilton, RL & Pollack, IF (1997). The molecular biology of ependymomas. Brain Pathol 7: 807–822.
Hermsen, MA, Joenje, H, Arwert, F, Braakhuis, BJ, Baak, JP, Westerveld, A & Slater, R (1997). Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncol 33: 414–418.
Honan, WP, Anderson, M, Carey, MP & Williams, B (1987). Familial subependymomas. Br J Neurosurg 1: 317–321.
Martuza, RL & Eldridge, R (1988). Neurofibromatosis 2 (Bilateral acoustic neurofibromatosis). N Engl J Med 318: 684–688.
Ng, H, Lau, K, Tse, JYM, Lo, K, Wong, JHC, Poon, W & Huang, DP (1995). Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 37: 764–773.
Nozaki, M, Tada, M, Matsumoto, R, Sawamura, Y, Abe, H & Iggo, RD (1998). Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay. Acta Neuropathol 95: 291–296.
Nijssen, PCG, Lekanne Deprez, RH, Tijssen, CC, Hagemeijer, A, Arnoldus, EPJ, Teepen, JLJM, Holl, R & Niermeyer, MF (1994). Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. J Neurol Neusosurg Psychiatry 57: 1245–1248.
Park, JP, Chaffee, S, Noll, WW & Rhodes, CH (1996). Constitutional de novo t (1;22) (p22; q11.2) and ependymoma. Cancer Genet Cytogenet 86: 150–152.
Rhodes, CH, Call, KM, Budarf, ML, Barnoski, BL, Bell, CJ, Emanuel, BS, Bigner, SH, Park, JP & Mohandas, TK (1997). Molecular studies of an ependymoma-associated constitutional t (1; 22) (p22; q11.2). Cytogenet Cell Genet 78: 247–252.
Rubio, M-P, Correa, KM, Ramesh, V, MacCollin, MM, Jacoby, LB, Von Deimling, A, Gusella, JF & Louis, DN (1994). Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54: 45–47.
Russell, DS & Rubinstein, LJ (1989). Tumours of the ependymoma group. In:Pathology of Tumours of the Nervous System, 5th edn Edward Arnold: London 187–219.
Ryken, TC, Robinson, RA & VanGilder, JC (1994). Familial occurrence of subependymoma. Report of two cases. J Neurosurg 80: 1108–1111.
Savard, ML & Gilchrist, DM (1989). Ependymomas in two sisters and a maternal male cousin with mosaicism with monosomy 22 in tumour. Pediatr Neurosci 15: 80–84.
Sirotkin, H, O’Donnell, H, DasGupta, R, Halford, S, St. Jore, B, Puech, A, Parimoo, S, Morrow, B, Skoultchi, A, Weissman, SM, Scambler, P & Kucherlapati, R (1997). Identification of a new catenin gene family member (ARVCF) from the region deleted in Velo-Cardio-Facial Syndrome. Genomics 41: 75–83.
Slavc, I, MacCollin, MM, Dunn, M, Jones, S, Sutton, L, Gusella, JF & Biegel, JA (1995). Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 64: 243–247.
Speicher, MR, Jauch, A, Walt, H, du Manoir, S, Ried, T, Jochum, W, Sulser, T & Cremer, T (1995). Correlation of microscopic phenotype with genotype in a formalin-fixed, paraffin-embedded testicular germ cell tumor with universal DNA amplification, comparative genomic hybridization, and interphase cytogenetics. Am J Pathol 146: 1332–1340.
Von Haken, MS, White, EC, Daneshvar-Shyesther, L, Sih, S, Choi, E, Kalra, R & Cogen, PH (1996). Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q sequences in sporadic pediatric ependymomas. Genes Chromosomes Cancer 17: 37–44.
Weremowicz, S, Kupsky, WJ, Morton, CC & Fletcher, JA (1992). Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet 61: 193–196.
Author information
Authors and Affiliations
Additional information
Department of Neurology, St Elisabeth Hospital, Tilburg, The Netherlands
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hulsebos, T., Oskam, N., Bijleveld, E. et al. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter–22q11.2. Br J Cancer 81, 1150–1154 (1999). https://doi.org/10.1038/sj.bjc.6690822
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690822
Keywords
This article is cited by
-
The genetic and epigenetic basis of ependymoma
Child's Nervous System (2009)
-
Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome
British Journal of Cancer (2008)
-
A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor
Journal of Human Genetics (2003)
-
Differential Involvement of Protein 4.1 Family Members DAL-1 and NF2 in Intracranial and Intraspinal Ependymomas
Modern Pathology (2002)